The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 979 | 40,549 | SH | SOLE | 40,549 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 1,631 | 112,160 | SH | SOLE | 112,160 | 0 | 0 | ||
ADAGIO THERAPEUTICS INC | COM | 00534A102 | 472 | 65,068 | SH | SOLE | 65,068 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 1,203 | 7,093 | SH | SOLE | 7,093 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 1,310 | 113,387 | SH | SOLE | 113,387 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 1,992 | 21,433 | SH | SOLE | 21,433 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 1,948 | 5,562 | SH | SOLE | 5,562 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 1,149 | 8,541 | SH | SOLE | 8,541 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 185 | 20,659 | SH | SOLE | 20,659 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 1,053 | 44,294 | SH | SOLE | 44,294 | 0 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 1,079 | 13,538 | SH | SOLE | 13,538 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 699 | 2,580 | SH | SOLE | 2,580 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 1,483 | 13,843 | SH | SOLE | 13,843 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 565 | 33,850 | SH | SOLE | 33,850 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 1,014 | 31,493 | SH | SOLE | 31,493 | 0 | 0 | ||
CATALYST PARTNRS ACQUISITN C | UNIT 99/99/9999 | G19550113 | 2,002 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 1,154 | 29,856 | SH | SOLE | 29,856 | 0 | 0 | ||
CHANGE HEALTHCARE INC | COM | 15912K100 | 3,466 | 162,100 | SH | SOLE | 162,100 | 0 | 0 | ||
COHERENT INC | COM | 192479103 | 3,625 | 13,600 | SH | SOLE | 13,600 | 0 | 0 | ||
COUPANG INC | CL A | 22266T109 | 7,529 | 256,264 | SH | SOLE | 256,264 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 1,505 | 52,982 | SH | SOLE | 52,982 | 0 | 0 | ||
CYRUSONE INC | COM | 23283R100 | 3,472 | 38,700 | SH | SOLE | 38,700 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 1,606 | 35,232 | SH | SOLE | 35,232 | 0 | 0 | ||
DELL TECHNOLOGIES INC | CL C | 24703L202 | 19,965 | 355,444 | SH | SOLE | 355,444 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 1,350 | 23,081 | SH | SOLE | 23,081 | 0 | 0 | ||
FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 578 | 40,612 | SH | SOLE | 40,612 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,591 | 89,963 | SH | SOLE | 89,963 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 630 | 27,010 | SH | SOLE | 27,010 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 1,463 | 113,752 | SH | SOLE | 113,752 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 1,217 | 11,298 | SH | SOLE | 11,298 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 960 | 40,619 | SH | SOLE | 40,619 | 0 | 0 | ||
IHS MARKIT LTD | SHS | G47567105 | 4,352 | 32,743 | SH | SOLE | 32,743 | 0 | 0 | ||
INSTIL BIO INC | COM | 45783C101 | 974 | 56,901 | SH | SOLE | 56,901 | 0 | 0 | ||
INVESCO DB COMMDY INDX TRCK | UNIT | 46138B103 | 881 | 42,396 | SH | SOLE | 42,396 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 687 | 44,967 | SH | SOLE | 44,967 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,272 | 66,639 | SH | SOLE | 66,639 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 1,606 | 34,487 | SH | SOLE | 34,487 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 1,691 | 101,144 | SH | SOLE | 101,144 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 820 | 46,264 | SH | SOLE | 46,264 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 1,150 | 82,124 | SH | SOLE | 82,124 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 867 | 54,012 | SH | SOLE | 54,012 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 1,712 | 53,840 | SH | SOLE | 53,840 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 1,355 | 9,236 | SH | SOLE | 9,236 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 1,125 | 23,751 | SH | SOLE | 23,751 | 0 | 0 | ||
MSD ACQUISITION CORP | UNIT 03/25/2026 | G5709C117 | 5,080 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 1,031 | 11,039 | SH | SOLE | 11,039 | 0 | 0 | ||
NUANCE COMMUNICATIONS INC | COM | 67020Y100 | 3,587 | 64,841 | SH | SOLE | 64,841 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 544 | 18,796 | SH | SOLE | 18,796 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 411 | 58,965 | SH | SOLE | 58,965 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 477 | 50,942 | SH | SOLE | 50,942 | 0 | 0 | ||
PEOPLES UNITED FINANCIAL INC | COM | 712704105 | 3,495 | 196,100 | SH | SOLE | 196,100 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 919 | 39,777 | SH | SOLE | 39,777 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 1,060 | 30,999 | SH | SOLE | 30,999 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 1,387 | 28,078 | SH | SOLE | 28,078 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 973 | 29,753 | SH | SOLE | 29,753 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 1,412 | 45,992 | SH | SOLE | 45,992 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 917 | 43,497 | SH | SOLE | 43,497 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 1,024 | 46,913 | SH | SOLE | 46,913 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 759 | 89,220 | SH | SOLE | 89,220 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 149 | 22,434 | SH | SOLE | 22,434 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 1,108 | 17,870 | SH | SOLE | 17,870 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 839 | 38,347 | SH | SOLE | 38,347 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 1,679 | 54,103 | SH | SOLE | 54,103 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 1,354 | 6,266 | SH | SOLE | 6,266 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 1,128 | 5,135 | SH | SOLE | 5,135 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 692 | 18,782 | SH | SOLE | 18,782 | 0 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM NEW | 92840H202 | 1,125 | 577,031 | SH | SOLE | 577,031 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,965 | 62,906 | SH | SOLE | 62,906 | 0 | 0 | ||
XILINX INC | COM | 983919101 | 5,125 | 24,173 | SH | SOLE | 24,173 | 0 | 0 |